Ads

 

Ads

 

Ads

 

Top Pharmaceutical Companies in S&P 500 List by Market Cap as on July-30-2023

Top Pharmaceutical Companies in S&P 500 List by Market Cap as on July-30-2023. Biggest and Top Pharmaceutical Companies in S&P 500 Companies by Market Cap. Largest Top Pharmaceutical Companies in S&P 500 List by Market Cap as on July-30-2023.
Metatag Title
Top Pharmaceutical Companies in S&P 500
Metatag Abstract
Top Pharmaceutical Companies in S&P 500, Biggest Pharmaceutical Companies in S&P 500, Largest Pharmaceutical Companies in S&P 500.
  1. Johnson & Johnson

    World Rank (Jan-05-2024)
    21
    Market Cap (Jan-05-2024)
    387.499 Billion USD
    World Rank (Jul-30-2023)
    15
    Market Cap (Jul-30-2023)
    453.430 Billion USD
    World Rank (Dec-25-2022)
    8
    Market Cap (Dec-25-2022)
    464.020 Billion USD
    World Rank (Jan-07-2022)
    14
    Market Cap (Jan-07-2022)
    457.94 Billion USD
    Annual Revenue in USD
    94,940 Million USD
    Annual Operating Income in USD
    23,700 Million USD
    Annual Net Income in USD
    17,940 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Johnson & Johnson manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2023, Johnson & Johnson has 155,800 employees across 60 countries. Headquarters is in USA.

    As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

    Facts About Company
    • Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD and annual net income was 17.94 Billion USD.
    • Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD and annual net income was 20.87 Billion USD.

    Johnson & Johnson annual sales by segment wise for period ending in Dec-2022:

  2. Eli Lilly and Company

    World Rank (Jan-05-2024)
    10
    Market Cap (Jan-05-2024)
    586.387 Billion USD
    World Rank (Jul-30-2023)
    16
    Market Cap (Jul-30-2023)
    435.220 Billion USD
    World Rank (Dec-25-2022)
    19
    Market Cap (Dec-25-2022)
    349.570 Billion USD
    World Rank (Jan-07-2022)
    39
    Market Cap (Jan-07-2022)
    248.24 Billion USD
    Annual Revenue in USD
    34,124 Million USD
    Annual Operating Income in USD
    10,787 Million USD
    Annual Net Income in USD
    5,240 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

    As of Jan-05-2024, Eli Lilly market cap was 586 Billion USD and it is World Top 10th rank company by market cap.

    Facts About Eli Lilly as on 2022:

    Facts About Company

    As on 2022, Eli Lilly has 39,000 employees.

    Eli Lilly annual revenue generated for period ending Dec-2022 was 28,541 million USD.

    Eli Lilly annual net income generated for period ending Dec-2022 was 6,244 million USD.

    Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

    Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

  3. Merck & Co

    World Rank (Jan-05-2024)
    28
    Market Cap (Jan-05-2024)
    296.506 Billion USD
    World Rank (Jul-30-2023)
    32
    Market Cap (Jul-30-2023)
    269.830 Billion USD
    World Rank (Dec-25-2022)
    30
    Market Cap (Dec-25-2022)
    283.610 Billion USD
    World Rank (Jan-07-2022)
    59
    Market Cap (Jan-07-2022)
    202.83 Billion USD
    Annual Revenue in USD
    59,280 Million USD
    Annual Operating Income in USD
    18,280 Million USD
    Annual Net Income in USD
    14,510 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Merck & Co is USA based healthcare and pharmaceutical multi-national company. Merck Company manufacture and sells innovative medicines, vaccines, and animal health products. Headquarters is in USA.

    Merck & Co focus on scientific innovation to deliver medicines and vaccines.

    Facts About Company

    As on 2022, Merck & Co has 69,000 employees.

    For year ending Dec-2022, Merck & Co annual revenue was 59.28 billion USD and annual net income was 14.51 billion USD.

    For year ending Dec-2021, Merck & Co annual revenue was 48.70 million USD and annual net income was 13.04 million USD.

    Total Assets as on Dec-2022 was 109,160 Million USD.

  4. Abbvie

    World Rank (Jan-05-2024)
    32
    Market Cap (Jan-05-2024)
    285.064 Billion USD
    World Rank (Jul-30-2023)
    33
    Market Cap (Jul-30-2023)
    266.140 Billion USD
    World Rank (Dec-25-2022)
    29
    Market Cap (Dec-25-2022)
    288.440 Billion USD
    World Rank (Jan-07-2022)
    46
    Market Cap (Jan-07-2022)
    238.45 Billion USD
    Annual Revenue in USD
    58,054 Million USD
    Annual Operating Income in USD
    18,814 Million USD
    Annual Net Income in USD
    11,782 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Abbvie is USA based healthcare and pharmaceutical multi-national company. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

    Facts About Company

    As on 2023, Abbvie has 50,000 employees.

    Abbvie annual revenue generated for period ending Dec-2022 was 58,054 million USD.

    Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

    Abbvie annual revenue generated for period ending Dec-2021 was 56,197 million USD.

    Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

    Total Assets as on Dec-2022 was 138,805 Million USD.

  5. Thermo Fisher Scientific

    World Rank (Jan-05-2024)
    52
    Market Cap (Jan-05-2024)
    207.621 Billion USD
    World Rank (Jul-30-2023)
    48
    Market Cap (Jul-30-2023)
    216.720 Billion USD
    World Rank (Dec-25-2022)
    39
    Market Cap (Dec-25-2022)
    212.050 Billion USD
    World Rank (Jan-07-2022)
    45
    Market Cap (Jan-07-2022)
    239.22 Billion USD
    Annual Revenue in USD
    44,915 Million USD
    Annual Operating Income in USD
    8,507 Million USD
    Annual Net Income in USD
    6,950 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Thermo Fisher Scientific is USA Based Bio-Technology and Healthcare Company. Develops and manufactures Medical Equipment. Headquarters is in USA.

    Facts About Company

    As on 2022, Thermo Fisher Scientific has 130,000 employees.

    Thermo Fisher Scientific annual revenue generated for period ending Dec-2022 was 44,915 million USD.

    Thermo Fisher Scientific annual net income generated for period ending Dec-2022 was 6,950 million USD.

    For Year ending December-2021, Thermo Fisher Scientific annual revenues was 39,211 Million USD and Net Income was 7,725 Million USD.

    As of December-2020, they had 80,000 employees.

  6. Pfizer

    World Rank (Jan-05-2024)
    67
    Market Cap (Jan-05-2024)
    167.868 Billion USD
    World Rank (Jul-30-2023)
    53
    Market Cap (Jul-30-2023)
    203.630 Billion USD
    World Rank (Dec-25-2022)
    28
    Market Cap (Dec-25-2022)
    290.940 Billion USD
    World Rank (Jan-07-2022)
    27
    Market Cap (Jan-07-2022)
    312.75 Billion USD
    Annual Revenue in USD
    100,330 Million USD
    Annual Operating Income in USD
    37,270 Million USD
    Annual Net Income in USD
    31,370 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world and their products are pharmaceutical drugs, vaccines.

    Facts About Company

    As of 2022, Pfizer has 83,000 employees.

    Pfizer annual revenue generated for period ending Dec-2022 was 100.33 billion USD.

    Pfizer annual net income generated for period ending Dec-2022 was 31.37 billion USD.

    As of 2021, Pfizer has 79,000 employees.

    Pfizer annual revenue generated for period ending Dec-2021 was 81.28 million USD.

    Pfizer annual net income generated for period ending Dec-2021 was 21.98 million USD.

  7. Abbott Laboratories

    World Rank (Jan-05-2024)
    57
    Market Cap (Jan-05-2024)
    192.668 Billion USD
    World Rank (Jul-30-2023)
    57
    Market Cap (Jul-30-2023)
    196.030 Billion USD
    World Rank (Dec-25-2022)
    51
    Market Cap (Dec-25-2022)
    188.620 Billion USD
    World Rank (Jan-07-2022)
    43
    Market Cap (Jan-07-2022)
    239.71 Billion USD
    Annual Revenue in USD
    43,653 Million USD
    Annual Operating Income in USD
    8,362 Million USD
    Annual Net Income in USD
    6,933 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Abbott Laboratories is USA based healthcare and pharmaceutical and is multi-national company. Abbott has presence in more than 150 countries. Key working areas of Abbott are related to Diabetes, Diagnostics, Neuro Modulation, Nutrition, Pharmaceuticals. They have over 113,000 employees as on 2021. Headquarters is in USA.

    Facts About Company

    As on 2022, Abbott Laboratories has 115,000 employees.

    Abbott Laboratories annual revenue generated for period ending Dec-2022 was 43,653 million USD.

    Abbott Laboratories annual net income generated for period ending Dec-2022 was 6,933 million USD.

    Abbott Laboratories annual revenue generated for period ending Dec-2021 was 43,075 million USD.

    Abbott Laboratories annual net income generated for period ending Dec-2021 was 7,071 million USD.

    Total Assets as on Dec-2021 was 75,196 Million USD.

  8. Bristol-Myers Squibb Company

    World Rank (Jan-05-2024)
    130
    Market Cap (Jan-05-2024)
    106.418 Billion USD
    World Rank (Jul-30-2023)
    100
    Market Cap (Jul-30-2023)
    129.010 Billion USD
    World Rank (Dec-25-2022)
    66
    Market Cap (Dec-25-2022)
    154.980 Billion USD
    World Rank (Jan-07-2022)
    96
    Market Cap (Jan-07-2022)
    139.46 Billion USD
    Annual Revenue in USD
    46,159 Million USD
    Annual Operating Income in USD
    9,104 Million USD
    Annual Net Income in USD
    6,327 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

    BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

    Company has over 32,200 employees as on 2021. Headquarters is in USA.

    BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

    BMS be the biopharma company that transforms patients' lives through science.

    Facts About Company

    As on 2022, Bristol-Myers Squibb has 34,300 employees.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2022 was 46,159 million USD.

    Bristol-Myers Squibb annual net income generated for period ending Dec-2022 was 6,327 million USD.

    As on 2021, BMS had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2021 was 46,385 million USD.

  9. Amgen

    World Rank (Jan-05-2024)
    73
    Market Cap (Jan-05-2024)
    162.250 Billion USD
    World Rank (Jul-30-2023)
    105
    Market Cap (Jul-30-2023)
    126.300 Billion USD
    World Rank (Dec-25-2022)
    80
    Market Cap (Dec-25-2022)
    140.820 Billion USD
    World Rank (Jan-07-2022)
    113
    Market Cap (Jan-07-2022)
    128.03 Billion USD
    Annual Revenue in USD
    26,323 Million USD
    Annual Operating Income in USD
    9,566 Million USD
    Annual Net Income in USD
    6,552 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

    Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

    Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

    Facts About Company

    As on 2022, Amgen has 25,200 employees.

    Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

    Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

    Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

    Split of Annual Revenue by business segment for period ending Dec-2021:

  10. Gilead Sciences

    World Rank (Jan-05-2024)
    133
    Market Cap (Jan-05-2024)
    105.265 Billion USD
    World Rank (Jul-30-2023)
    154
    Market Cap (Jul-30-2023)
    95.871 Billion USD
    World Rank (Dec-25-2022)
    120
    Market Cap (Dec-25-2022)
    106.300 Billion USD
    World Rank (Jan-07-2022)
    180
    Market Cap (Jan-07-2022)
    89.39 Billion USD
    Annual Revenue in USD
    27,281 Million USD
    Annual Operating Income in USD
    10,974 Million USD
    Annual Net Income in USD
    4,592 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    GILEAD SCIENCES INC is world’s largest bio-pharmaceutical companies. As on Dec-2021, Gilead Sciences had 14,400 employees across six continents and headquarters is in USA,

    As on 2022, GILEAD SCIENCES INC has 17,000 employees.

    GILEAD SCIENCES INC annual revenue generated for period ending Dec-2022 was 27,281 million USD.

    GILEAD SCIENCES INC annual net loss generated for period ending Dec-2022 was 4,592 million USD.

Share

Ads